title: Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG.
authors.affiliation: Department of Neurology, The University of Alabama, Birmingham, AL 35294, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Hatanaka
authors.forename: S
authors.initials: S
authors.lastname: Hemmi
authors.forename: M B
authors.initials: MB
authors.lastname: Morgan
authors.forename: M L
authors.initials: ML
authors.lastname: Scheufele
authors.forename: G C
authors.initials: GC
authors.lastname: Claussen
authors.forename: G I
authors.initials: GI
authors.lastname: Wolfe
authors.forename: S J
authors.initials: SJ
authors.lastname: Oh
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000097:blood*; D015984:Causality; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D018450:Disease Progression; D004351:Drug Resistance / Q000276:immunology*; D004491:Edrophonium / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D009157:Myasthenia Gravis / Q000097:blood / Q000188:drug therapy* / Q000276:immunology*; D018579:Patient Selection; D011237:Predictive Value of Tests; D011729:Pyridostigmine Bromide / Q000009:adverse effects; D020794:Receptor Protein-Tyrosine Kinases / Q000276:immunology*; D011950:Receptors, Cholinergic / Q000276:immunology*
chemical_list: D001323:Autoantibodies; D002800:Cholinesterase Inhibitors; D011950:Receptors, Cholinergic; D004491:Edrophonium; C095714:MUSK protein, human; D020794:Receptor Protein-Tyrosine Kinases; D011729:Pyridostigmine Bromide